Genscript Biotech (OTCMKTS:GNNSF) Trading Down 25%

Genscript Biotech Co. (OTCMKTS:GNNSFGet Free Report) shares were down 25% on Monday . The company traded as low as C$1.05 and last traded at C$1.05. Approximately 2,350 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 66,788 shares. The stock had previously closed at C$1.40.

Genscript Biotech Price Performance

The stock has a fifty day simple moving average of C$1.62 and a two-hundred day simple moving average of C$2.12.

Genscript Biotech Company Profile

(Get Free Report)

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.

Featured Articles

Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with's FREE daily email newsletter.